Efficacy response of inhaled HFA-albuterol delivered via the breath-actuated Autohaler™ inhalation device is comparable to dose in patients with asthma

Journal of Asthma

Volumn 40, Issue 5, 2003, Pages 487-495

  Gross, Gary ^a   Cohen, Robert M ^b   Guy, Harold ^c  

^a Pharmaceut Res/Consulting Inc   (United States)

^b Allerg and Asthma Clin Res Ctr   (United States)

^c Inst of Healthcare Assessment Inc   (United States)

Author keywords

Albuterol; Asthma; Beta2 agonist; Bronchodilator; HFA; Salbutamol

Indexed keywords

SALBUTAMOL; SALBUTAMOL SULFATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DIARRHEA; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; INHALATION; INHALER; MALE; METERED DOSE INHALER; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AEROSOL PROPELLANTS; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYDROCARBONS, FLUORINATED; MALE; METERED DOSE INHALERS; TREATMENT OUTCOME;

EID: 0141620218     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120018777     Document Type: Article

References (23)

1. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI Respir Med 2000; 94:496-500.
2. McFadden ER. Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse. J Allergy Clin Immunol 1995; 96:278-283.
3. Crompton GK. Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis 1982; 63:101-104.
4. Epstein SW, Manning CPR, Ashley MJ, Corey PN. Survey of the use of pressurized aerosol inhalers. Can Med Assoc 1979; 120:813-816.
5. Hartert V, Windom HH, Peebles RS, Freidhoff LR, Togias A. Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals. Am J Med 1996; 100:386-394.
6. Finlay WH, Zuberbuhler P. In vitro comparison of albuterol hydrofluoroalkane (Airomir) metered dose. J Aerosol Med 1999; 12:285-291.
7. Wildhaber JH, Hayden MJ, Dore ND, Devadason SG, LeSouef PN. Albuterol delivery from a hydrofluoroalkane pressurized metered-dose inhaler in pediatric ventilator circuits: an in vitro study. Chest 1998; 113:186-191.
8. Shapiro GS, Klinger NM, Ekholm BP, Colice GL. Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol and chlorofluorocarbons-11/12 (CFC) albuterol in children with asthma. J Asthma 2000; 3:667-675.
9. 2-agonist. Am J Respir Crit Care Med 1999; 160:354-357.
10. Ramsdell JW, Colice GL, Ekholm BP, Klinger NM. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma. Ann Allergy Asthma Immunol 1998; 81:593-599.
11. Bronsky E, Ekholm BP, Klinger NM, Colice GL. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol. J Asthma 1999; 36:107-114.
12. Ramsdell JW, Klinger NM, Ekholm BP, Colice GL. Safety of long-term treatment with HFA albuterol. Chest 1999; 115:945-951.
13. Kleerup EC, Tashkin DP, Cline AC, Ekholm BP. Cumulative dose-response study of non-CFC propellant HFA 134a albuterol sulfate metered-dose inhaler in patients with asthma. Chest 1996; 109:702-707.
14. Donnell D, Harrison LI, Ward S, Klinger NM, Ekholm BP, Cooper KM, Porietis I, McEwen J. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler. Eur J Clin Pharmacol 1995; 48:474-477.
15. Donnell D. Inhaled corticosteroid delivery systems: clinical role of a breath-actuated device. Eur Rev Med Pharmacol Sci 2001; 5:7-16.
16. Marshik PL, Larsen JS, Leach CL, Halverson PC, Ekholm BP, Amies MH, Kaiser HB, Weisberg SC, Sellers JA. A novel breath actuated device (Autohaler) consistently actuates during the early phase of inspiration. J Aerosol Med 1995; 8:187-195.
17. Woodman K, Bremner P, Burgess C, Crane J, Pearce N, Beasley R. A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients. Curr Med Res Opin 1993; 13:61-69.
18. Leach C. Effect of formulation parameters on Hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans. J Allergy Clin Immunol 1999; 104:S250-252.
19. Finney DJ. A computer program for parallel line bioassays. J Pharmacol Exp Ther 1976; 198:497-506.
20. Dockhorn R, Vanden-Burgt JA, Ekholm BP, Donnell D, Cullen MT. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler in patients with asthma. J Allergy Clin Immunol 1995; 96:50-56.
21. Zureik M, Delacourt C. Evaluation of the ability of asthmatic children to use a breath-actuated pressurized inhaler. Arch Pediatr 1999; 6:1172-1178.
22. Le Cocguic Y, Zureik M. Evaluation of the everyday use of a metered dose aerosol triggered by inhalation (the "Autohaler" system). Rev Pneumol Clin 1997; 53:13-19.
23. Terzano C, Mannino F. Probability of particle and albuterol deposition in the respiratory tract: comparison between MDI and Autohaler. Monaldi Arch Chest Dis 1996; 51:236-242.